Global Cervical Dystonia Market Research Report Forecast to 2023

Global Cervical Dystonia Market Research Report Forecast to 2023

ID: MRFR/Pharma/0907-HCRR | July, 2017 | Region: Global | 85 pages | Half-Cooked Research Reports

Global Cervical Dystonia Market Research Report, By Type (Torticollis, Retrocollis, Laterocollis and others), By Treatment (Oral Therapy, Intravenous, Surgery and other), on End User (Hospital, Clinics and other) - Forecast till 2023


Study Objectives global cervical dystonia market



  • To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the cervical dystonia market

  • Detail information about the factors affecting the growth of the global cervical dystonia market.

  • Detail analysis of global cervical dystonia market with respect to all the possible segmentation of the market.

  • Detail analysis of emerging key players for the market with their effective strategies and factors that influences the market on global scale.

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global cervical dystonia market.

  • Analysis of the market of the different factors like- price analysis, supply chain analysis, porters five force analysis etc.

  • Detail information on the possible segments and sub segments of the market. And regional analysis of the market- North America, Europe, Asia Pacific and Middle East and Africa.

  • Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

  • Detail information on trends and the opportunities in various regions.


Intended Audience



  • Pharmaceutical companies working in cervical dystonia

  • Research and Development (R&D) Companies

  • Government and Independent Research Laboratories

  • Contract Research Organizations (CROs)

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Figure 1- Global cervical dystonia market share, by region

Cervical dystonia Market-


Market Scenario:
Cervical dystonia is a rare disease also known as spasmodic torticollis. It is one of the painful chronic neurological movement disorder causing the neck to turn involuntary to any of the direction. It is a rare disease. The major driving factors for the market for cervical dystonia is increasing aging population across the globe. Females are more likely to be get affected by cervical dystonia. Beside this increasing number of treatment for cervical Dystonia and improvement in infrastructure has provided fuel for the growth of the market. On other hand success rate of the treatment and increasing cost of the treatment is the major cause for restraining the growth of cervical Dystonia market.
Global cervical dystonia market is expected to grow at a CAGR of 5% during forecasted period 2017-2023.


Segmentation
Global cervical dystonia market has been segmented on the basis of type which includes torticollis, retrocollis, laterocollis and others.  On the basis of treatment they are segmented into oral therapy, intravenous, surgery and other. On the basis of end user they are segmented into hospital, clinics and other.


Regional Analysis
On regional basis, global cervical dystonia market is dominated by North America which is followed by Europe. Increasing prevalence of cervical dystonia and increasing aging population is the major factor for growth of this market in this region. Asia Pacific is the fastest growing region for the cervical dystonia market. While due to less development in pharmaceutical and medical sector Middle East and Africa contribute least in cervical dystonia market.


Key players for global cervical dystonia market
ALLERGAN (Ireland), Solstice Neurosciences LLC, Ipsen Biopharmaceuticals Inc. (France), Merz Inc (US), Addex Therapeutics (Switzerland) Revance Therapeutics Inc. (US) and many other.


Market Assessment

Cervical dystonia Market


The report for global cervical dystonia market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.


 


 

TABLE OF CONTENTS

1    INTRODUCTION    

      1.1    DEFINITION    

      1.2    SCOPE OF STUDY    

            1.2.1    RESEARCH OBJECTIVE    

            1.2.2    ASSUMPTIONS & LIMITATIONS    

                1.2.2.1    ASSUMPTIONS    

                1.2.2.2    LIMITATIONS    

      1.3    MARKET STRUCTURE:    

2    RESEARCH METHODOLOGY    

      2.1    RESEARCH PROCESS:    

      2.2    PRIMARY RESEARCH    

      2.3    SECONDARY RESEARCH:    

3    MARKET DYNAMICS    

      3.1    DRIVERS    

      3.2    RESTRAINTS        

      3.3    OPPORTUNITIES    

      3.4    MACROECONOMIC INDICATORS    

4    MARKET FACTOR ANALYSIS    

      4.1    PORTERS FIVE FORCES MODEL    

      4.2    BARGAINING POWER OF SUPPLIERS    

      4.3    BARGAINING POWER OF BUYERS    

      4.4    THREAT OF NEW ENTRANTS    

      4.5    THREAT OF SUBSTITUTES    

      4.6    INTENSITY OF RIVALRY    

5.    GLOBAL CERVICAL DYSTONIA MARKET, BY DRUG TYPE 

      5.1    TORTICOLLIS

      5.2    RETROCOLLIS

      5.3    LATEROCOLLIS 

      5.4    OTHERS

6.    GLOBAL CERVICAL DYSTONIA MARKET, BY TREATMENT

      6.1    ORAL THERAPY

      6.2    INTRAVENOUS 

      6.3    SURGERY

      6.4    OTHER

7.    GLOBAL CERVICAL DYSTONIA MARKET, BY END USER

      7.1    HOSPITAL

      7.2    CLINICS 

      7.3    OTHER

8.     GLOBAL CERVICAL DYSTONIA MARKET, BY REGION

      8.1    INTRODUCTION

      8.2    NORTH AMERICA

            8.2.1    US

            8.2.2    CANADA

      8.3    EUROPE

            8.3.1    WESTERN EUROPE

                8.3.1.1    GERMANY

                8.3.1.2    FRANCE

                8.3.1.3    ITALY

                8.3.1.3    SPAIN

                8.3.1.5    UK

                8.3.1.6    REST OF WESTERN EUROPE

            8.3.2    EASTERN EUROPE

      8.4    ASIA

            8.4.1    JAPAN

            8.4.2    CHINA

            8.4.3    INDIA

            8.4.4    AUSTRALIA

            8.4.5    REPUBLIC OF KOREA

      8.5    REST OF ASIA-PACIFIC

      8.6    MIDDLE EAST & AFRICA

9.    COMPETITIVE LANDSCAPE    

      9.1    MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS    

            9.1.1    STRATEGIC PARTNERSHIP    

            9.1.2    MERGER & ACQUISITION    

10    COMPANY PROFILE    

      10.1    ALLERGAN

            10.1.1    OVERVIEW    

            10.1.2    PRODUCT OVERVIEW    

            10.1.3    FINANCIALS    

            10.1.4    KEY DEVELOPMENTS    

      10.2    SOLSTICE NEUROSCIENCES LLC

            10.2.1    OVERVIEW    

            10.2.2    PRODUCT OVERVIEW    

            10.2.3    FINANCIALS    

            10.2.4    KEY DEVELOPMENTS    

      10.3    IPSEN BIOPHARMACEUTICALS INC 

            10.3.1    OVERVIEW

            10.3.2    PRODUCT OVERVIEW    

            10.3.3    FINANCIALS

            10.3.4    STRATEGY    

            10.3.5    KEY DEVELOPMENT    

      10.4    REVANCE THERAPEUTICS INC. 

            10.4.1    OVERVIEW

            10.4.2    PRODUCT OVERVIEW

            10.4.3    FINANCIALS

            10.4.4    KEY DEVELOPMENTS    

      10.5    MERZ INC

            10.5.1    OVERVIEW

            10.5.2    PRODUCT OVERVIEW    

            10.5.3    FINANCIALS    

            10.5.4    KEY DEVELOPMENTS    

      10.6    OTHERS